A recent phase III study for patients with metastatic castrate resistant PrCa, SWOG 0421 [5], showed high levels of CTCs at baseline were associated with an elevated PSA and increased bone pain, with an increase in CTC number highly correlated with worse OS [5]. This evidence concerns the gene KLK3 and pure red-cell aplasia.